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‘One day I will find the right words, and they will be simple’1 – Rethinking DNACPR at 
a national level 
Do Not Attempt Cardio-Pulmonary Resuscitation (DNACPR) notices remain controversial. 
After all, they are telling a patient or her family that she is dying and cannot be saved. The 
clinical grounds for adopting a DNACPR are centred upon either the futility of such 
intervention, or that the disadvantages heavily outweigh any possible benefits so that it is not 
in the patient’s best interests.2 Equally, a competent patient may also request a DNACPR; the 
rationality, reasonableness or wisdom of which cannot be disputed by the clinician.3  But 
discussing DNACPR notices is not easy and practices vary between regions, and between 
institutions. Over the last decade, a number of different Trusts have initiated reviews to 
encourage better communication and documentation of DNACPR. Yet, empirical studies 
reveal:  
‘evidence of variation and suboptimal practice in relation to DNACPR across health-
care settings, reduced quality of care for patients with DNACPR orders and 
inappropriate expectations of the outcome of CPR among family members and the 
general public.’4 
Most damning of all,  
‘Health-care professionals do not discuss DNACPR with patients and their families 
and they do not communicate adequately with each other about a patient’s DNACPR 
status. Doctors either avoid discussing with patients/making the decision or do not see 
this as a priority. There is a lack of knowledge about process and confusion over 
documentation within and between health-care organisations.’5 
 
Further, inappropriate use of CPR due to confused procedures and lack of initial discussion 
has been documented and identified as a cause of patient suffering.6 A two-fold need is thus 
apparent: (i) better management of patient understanding and expectation; and (ii) coherent, 
standard process for initiating and documenting treatment discussions. The Resuscitation 
Council (UK) has recently made recommendations in order to deal with some of the 
difficulties identified above, yet their proposals remain advisory.7 This discussion reviews 
current practices and suggests that the time has come for a national standardised approach in 
England and Wales8 to the process of initiating and documenting DNACPR, along with a 
dedicated programme to increase public understanding of what is involved. Importantly, such 
an approach would both ensure that the respective legal rights and obligations of patients and 
professionals are respected, and provide clear public health gains.  At the very least, a 
national conversation can help achieve common understandings and expectations, which will 
go some way towards ensuring that the patient remains at the heart of the decision-making 
process. 
 
Context of DNACPR 
Most complaints to the Parliament and Health Services Ombudsman concern end-of-life care 
and treatment in hospital, and over half of these raise poor communication as the reason for 
concern: 
‘Communication failings appear at all levels; between clinicians and patients; between 
clinicians and family; within clinical teams; and finally, between the hospital and care 
in the community.[…] What is clear … is that healthcare professionals are not always 
having the open and honest conversations that are necessary in order for carers and 
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family members to understand both the severity of the situation and also the choices 
that will need to be made.’9 
It is not therefore a surprise that the Health Select Committee, Fifth Report End-of-Life Care 
(2015) recommended review of DNACPR in acute hospital settings and consideration in the 
context of an overall treatment plan.    
Current practices 
A systematic review published in 2015 identified the variety of nomenclature, forms and 
procedural guidelines set at a local level.10  For example, out of those sampled, the terms 
‘DNACPR’, ‘DNAR’, ‘not for CPR’ or ‘AND’ (Allow Natural Death) were used. There is 
also much diversity on whether there is any review period set for the forms, who should 
complete and sign them, the duration of the validity of each decision, and on the portability of 
the document. For some areas, the document ‘travels’ with the patient and includes access for 
ambulance and community staff, but this varies between Trusts.11  
What is clear from the systematic review and other empirical research carried out to date,12 is 
that there is an unease amongst medical professionals about the uncertainty: (i) as to the right 
time at which this judgment should be made; and (ii) as to the reaction of the patient and/or 
family to the idea of not attempting resuscitation. The difficulty is exacerbated by a lack of 
understanding amongst the general public of what CPR actually involves (often informed by 
hyperbolic media reports about unwieldy use of DNACPR notices and glamourised 
representations of successful CPR bringing someone ‘back to life’) and the fear that a 
DNACPR actually goes beyond simple resuscitation and may lead to a reduction in the 
overall level of care.13   
A number of Trusts have adopted revised forms and practice in the use of DNACPR. The 
‘Deciding Right’ programme adopted in the North East was identified as best practice14 and 
involves a distinct DNACPR form which allows for detailed documentation of the reasons 
behind the decision. In Devon, ‘Treatment Escalation Plans’ were pioneered and have been 
adopted in some other Trusts with the aim of being introduced at an earlier stage providing 
the opportunity for discussion on a variety of treatment options.15 The Universal Form of 
Treatment Options has been piloted in Cambridge (and was referred to in the Tracey case 
discussed below) and includes wider treatment options as well as DNACPR. The most recent 
proposals from the Resuscitation Council (UK) aim to offer a unified, consistent approach to 
end-of-life treatment decisions and are seen as a step towards ‘changing the culture of 
resuscitation decision-making’.16 Nevertheless, I would argue that in order to make real 
progress, a mandated national programme would be beneficial.  
Towards a national approach? 
The question of the need for the Secretary of State to impose a national standardised national 
framework policy for the use of DNACPR orders was raised in the much publicised case of 
Janet Tracey17 concerning the imposition of a DNACPR notice without consulting either the 
patient or her family. In this case, the claimants suggested that the Secretary of State should 
be under such a duty. However, the Court of Appeal held that the duty imposed upon the 
Secretary of State was discharged by the commendation of the professional Joint Statement18  
coupled with the use of a Health Service Circular on Resuscitation Policy which included 
reference to the legal duties on Trusts to ensure that patients (and where relevant families or 
carers) are involved in the process.19  However, the Court did find that: 
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‘consistency on important matters of policy (rather than minor matters) is desirable. 
If there are inconsistencies (or indeed any other deficiencies) in the involvement of 
patients in DNACPR decisions, they need to be resolved’.20 
I have already identified that there are discrepancies in practice and an overall desire to 
improve how and when such decisions are made. The current work of the Resuscitation 
Council (UK) is clearly grappling with this, but a standardised national approach would have 
a number of advantages for both medical professionals and the public. 
 
(i) Public engagement and education: 
A national strategy gives the opportunity for public engagement and education. Ultimately, it 
is this which is at the heart of a successful DNACPR policy because it allows for improved 
communication and understanding between professionals and the public. This has been 
evidenced in other jurisdictions where greater investment in education has been found to be 
key in improving both understanding and use of DNACPR notices. For example, in Australia, 
a Government initiative has increased education of overall advance care planning as studies 
there had shown that the lack of a standardised national programme was part of the difficulty 
in ensuring consistent, coherent and appropriate decision-making, especially concerning end-
of-life issues. 21 In the UK, the Dying Matters Coalition has gone some way to supporting 
better public discussion of dying and bereavement,22 but its focus is rather on the dying 
process and death. Thus, there remains a need for a certain level of myth-busting with respect 
to what CPR is for and what it can do. Public debate would thus allow clarity to be brought to 
what is involved and encourage the adoption of simple, consistent terminology. It would 
enable clearer understanding of the clinical realities of CPR and provide assurance that such 
notices relate only to CPR and not overall care at end-of-life. Most importantly, it would 
contribute to respecting the legal obligations concerning DNACPR. As the Tracey case 
highlighted, there is a presumption in law of the involvement of the patient in the decision-
making process and part of the procedural obligations on healthcare Trusts requires that 
decision-making policies are clear, accessible and available to the public. A national public 
awareness campaign coupled with national information leaflets could ensure this and provide 
consistent information across all regions and all health care settings. British Columbia in 
Canada has adopted a high profile campaign to increase public understanding of advance care 
planning and CPR decisions. A leaflet explaining ‘Medical Orders for Scope of Treatment’ 
(MOST) encourages relevant discussion with clinicians (‘early and often’) about the 
treatment options available.23 Such patient education could be a useful element in ensuring 
patient involvement and understanding on this side of the Atlantic. 
 
(ii) Professional development 
Greater public engagement would also be of benefit to practitioners as the studies to date 
reveal that even for professionals, the DNACPR may sometimes dictate an overall care plan, 
when in fact it should only be an element within it.24 There could be clearer guidance as to 
when it is appropriate to instigate discussion relating to CPR: if it seen as part of the overall 
care plan, it would be easier to engage with it an earlier opportunity, perhaps while a patient 
is still able to communicate her wishes and opinions. This would ensure better respect for an 
individual’s rights and facilitate the assessment of each patient’s best interests, as required by 
law. The Tracey judgment makes clear that an individual’s right to a private life, protected 
under article 8 of the European Convention on Human Rights, imposes an obligation for 
patients to be involved in the decision-making process where that decision relates to an 
intimate aspect of their life. Further, the Mental Capacity Act 2005 expressly requires a 
doctor to consider the patient’s best interests, which include her ‘wishes and 
feelings’…’beliefs and values’.25 The Government’s response to the Review of Choice in 
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End-of-Life Care26 in 2016 confirmed pilot projects which will explore new ways to support 
clinicians to initiate meaningful conversations with patients.27 By emphasising that such 
discussions are an essential part of clinical intervention may go some way to ensuring that 
these conversations take place, and with appropriately qualified and trained staff.28Further 
consideration needs to be given to the timing of such discussions and the normalisation of 
raising CPR within the context of overall care for certain patients.29 Clearly for some patients, 
CPR will not fall to be considered. For others, it will be helpful to include CPR in the 
treatment plan and to bear in mind that ultimately, the decision concerning CPR is one made 
at the time it is needed by the health professional who is present. Having a clearly 
documented DNACPR notice as to the reasons for the decision, whilst not binding, clearly 
assists the professional to act in that patient’s best interests.   
 
An additional advantage of a national structure is that it could facilitate consideration of 
Advance Directives or Lasting Power of Attorney (LPA). Evidence suggest some confusion 
for practitioners as to the differences between these mechanisms and how they fit in with 
DNACPR orders.30 It would also publicise these legal mechanisms to encourage greater 
uptake. The Health Select Committee Report expressly notes limited recourse to LPA and 
recommended that the cost of such should be reviewed and reduced.31 It is clear that as we 
live longer and are likely to suffer more co-morbidities which eventually render us incapable 
of making decisions, more of us may wish to draw up either advance directives or appoint 
someone to speak for us should we become incompetent. 
Just like an advance directive or LPA, the DNACPR as part of the overall care plan should be 
a portable document, available at all points of care delivery providing consistency for 
healthcare workers in different sectors (acute, community, ambulance, nursing home etc..). It 
would also mean that where practitioners move from one trust to another, there would be no 
need for further training to convert to an alternative format. 
(iii) Public health benefits? 
There are likely public health benefits from a robust, standardised national plan which places 
early discussion of CPR at the forefront insofar as it is to be expected that incidences of 
inappropriate CPR would be reduced. Although it has been found that even where a 
DNACPR notice has been in a patient’s notes, CPR has nevertheless been carried out (and, 
not surprisingly, most often with unsuccessful outcome)32 it is to be hoped that where patients 
and families are realistically informed and involved in the decision about CPR, clinicians will 
be more comfortable in respecting that decision. At present, the common discomfort or 
unwillingness of clinicians to discuss CPR, coupled with lack of knowledge or understanding 
of the procedure for the patient, mean that any DNACPR notice is not treated with sufficient 
respect. The NCEPOD Report 2012 noted a number of interventions despite the existence of 
a DNACPR decision. It follows that if less (inappropriate and unsuccessful) CPR is 
undertaken, there will be a knock-on benefit in terms of diminishing on-going futile 
treatment, and potentially admission to ICU, which may be occasioned if CPR is attempted 
where it should not be.  
What is central to ensuring respect for both professional and legal obligations is that the use 
of DNACPR or any other treatment decisions are not tick-box exercises, and that each 
clinician feels supported in taking the time to conduct the necessary discussions. The duty to 
consult and involve a patient and her family in the decision-making process involves a 
discussion, and one which should be seen as a crucial element in a patient’s care.33 This 
discussion should be undertaken at the earliest stage where the patient’s wishes and feelings 
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can be aired and taken into account, wherever possible The process must also allow for any 
decisions taken to be reviewed if the situation changes. The conversation must be clinician-
led, but patient-centred. As William Osler revealed over a century ago, ‘It is much more 
important to know what sort of a patient has a disease than what sort of a disease a patient 
has’.  
In terms of DNACPR, neither the difficulty of the discussion, nor the mis-placed expectations 
of the public, justify excluding the patient or her family from the decision-making process. 
The sooner we open a national conversation on this, the sooner we will be able to ensure that 
dignity of each and every patient is respected and that we are all using the same, simple 
words to mean the same things.   
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